MCK Trading Analysis - 10/09/2026 04:02 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and context for McKesson Corporation (MCK) that may frame the current data:

• McKesson reported fiscal Q2 2026 results in late August with steady prescription volume growth across its U.S. Pharmaceutical segment, reinforcing its defensive healthcare distribution profile.
• The company announced a quarterly dividend with ex-dividend date of 2026-09-01, reflected in the fundamentals data provided.
• Managed care and pharmacy benefit manager negotiations throughout 2026 have kept drug distribution margins in focus; MCK remains a low-beta large-cap relative to broader markets.
• No major negative regulatory action has surfaced recently, though opioid-related settlement oversight continues as a long-term overhang for distributors.
• Broad healthcare sector rotation into defensive names may support steady accumulation as shown in the embedded price and options data.

Context: The above headlines are external knowledge and are separated from the data-driven sections below, which rely strictly on the embedded JSON datasets.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for MCK:

• Trailing P/E is 24.80 with trailing EPS of 37.53; market cap is 109,760,157,800.00 and shares outstanding 116,590,000.00.
• Dividend yield is 0.40% with dividend rate of 3.76 and ex-dividend date 2026-09-01.
• Beta is 0.17 indicating very low market sensitivity; 52-week range is 723.68 to 999.00.
• Institutional ownership is 58.31% and average volume is 851,000.00.
• Historical volatility is 26.17%; fiscal year end is 2026-03-01.
• PEG ratio, forward P/E, forward EPS, price-to-book, total revenue, revenue growth, ROE, profit margins, debt-to-equity, free cash flow, recommendation key, target mean price, and analyst opinions are all null in the data.

Fundamental strength is shown via low beta, solid EPS, and large market cap; however, absent margin and growth data limit deeper comparison to sector peers. Valuation at 24.80 P/E with no PEG available cannot be benchmarked. Fundamentals show stability that aligns with the bullish technical and sentiment embedded data.

Current Market Position

From the embedded data, the daily history shows 2026-10-08 close at 934.61 with intraday high 938.51 and low 906.65. Minute bars for 2026-10-08 open at 906.65 and climb to 917.98 by 09:50; last bars for 2026-10-09 show price around 940.77 to 941.97, indicating continued upward drift.

Key observational levels from data: 30-day low 847.28, 30-day high 938.51, prior daily close 934.61, and upper Bollinger at 933.70. Price is at the top of the 30-day range.

Technical Analysis

Price is above SMA 5 (917.41), SMA 20 (889.55), and SMA 50 (882.44) showing bullish alignment with no bearish crossovers. RSI at 67.44 signals strong momentum near overbought but not extreme. MACD histogram positive at 1.97 confirms bullish momentum. Bollinger upper at 933.70 is breached by close 934.61 indicating expansion. Price sits at 30-day high boundary (938.51) after ranging from 847.28.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment shows Bullish with call dollar volume 265,650.00 and put dollar volume 110,820.00.

Call Volume: 265,650.00 (70.6%) Put Volume: 110,820.00 (29.4%) Total: 376,470.00

Call contracts 41 vs put 36, call trades 10 vs put 6. Pure directional conviction favors calls, supporting near-term upside expectation. No divergence from technical bullish picture is present in the embedded data.

Key Price Levels (Observational Only)